BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37522989)

  • 21. Efficacy and safety of gemcitabine monotherapy for patients with advanced biliary tract cancer.
    Yokoyama T; Yoshida H; Makino H; Maruyama H; Suzuki S; Matsutani T; Matsushita A; Hirakata A; Sasajima K; Uchida E
    J Nippon Med Sch; 2012; 79(3):204-12. PubMed ID: 22791122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical Resection for Pulmonary Metastasis from Pancreatic and Biliary Tract Cancer.
    Tagawa T; Ito K; Fukuzawa K; Okamoto T; Yoshimura A; Kawasaki T; Masuda T; Iwaki K; Terashi T; Okamoto M; Shiromizu A; Motohiro A; Maehara Y
    Anticancer Res; 2017 Mar; 37(3):1413-1416. PubMed ID: 28314312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the initial recurrence site on prognosis after radical surgery for colorectal cancer: a retrospective cohort study.
    Pu H; Chen Y; Shen R; Zhang Y; Yang D; Liu L; Dong X; Yang G
    World J Surg Oncol; 2023 Apr; 21(1):137. PubMed ID: 37101165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer.
    Li H; Zhao T; Ji X; Liang S; Wang Z; Yang Y; Yin J; Wang R
    Tumour Biol; 2016 Mar; 37(3):3535-42. PubMed ID: 26453118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer.
    Gbolahan OB; Zhi X; Liu Y; Shah MM; Kooby DA; Alese OB
    JAMA Netw Open; 2024 Jan; 7(1):e2351502. PubMed ID: 38206623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastasectomy for recurrent or metastatic biliary tract cancers: A single center experience.
    Park I; Kim YS; Sym SJ; Ahn HK; Kim KK; Park YH; Lee JN; Shin DB
    Indian J Cancer; 2017; 54(1):57-62. PubMed ID: 29199665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Completion of adjuvant S-1 chemotherapy after surgical resection for biliary tract cancer: A single center experience.
    Iwaki K; Yoh T; Nishino H; Nishio T; Koyama Y; Ogiso S; Ishii T; Kanai M; Hatano E
    Asian J Surg; 2024 Mar; 47(3):1383-1388. PubMed ID: 38160154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
    Kosuga T; Shiozaki A; Fujiwara H; Ichikawa D; Okamoto K; Komatsu S; Otsuji E
    World J Surg; 2011 Apr; 35(4):798-804. PubMed ID: 21312037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer.
    McNamara MG; Templeton AJ; Maganti M; Walter T; Horgan AM; McKeever L; Min T; Amir E; Knox JJ
    Eur J Cancer; 2014 Jun; 50(9):1581-9. PubMed ID: 24630393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the initial site of recurrence on prognosis after curative surgery for primary lung cancer.
    Isaka T; Ito H; Nakayama H; Yokose T; Saito H; Masuda M
    Eur J Cardiothorac Surg; 2022 Mar; 61(4):778-786. PubMed ID: 34686875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment.
    Kondo S; Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Furuse J; Saito H; Tsuyuguchi T; Yamamoto M; Kayahara M; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Hirano S; Amano H; Miura F; ; ;
    J Hepatobiliary Pancreat Surg; 2008; 15(1):41-54. PubMed ID: 18274843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 33. Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy.
    Yamashita K; Watanabe M; Mine S; Kurogochi T; Okamura A; Hayami M; Imamura Y
    World J Surg; 2017 Sep; 41(9):2337-2344. PubMed ID: 28432391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A combined prediction model for biliary tract cancer using the prognostic nutritional index and pathological findings: a single-center retrospective study.
    Utsumi M; Kitada K; Tokunaga N; Kato T; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
    BMC Gastroenterol; 2021 Oct; 21(1):375. PubMed ID: 34645392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC).
    Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A
    Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer.
    Okumura Y; Noda T; Eguchi H; Sakamoto T; Iwagami Y; Yamada D; Asaoka T; Wada H; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
    Ann Surg Oncol; 2018 Nov; 25(12):3728-3737. PubMed ID: 30105440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difficulty of adjuvant chemotherapy administration in patients with biliary tract cancer.
    Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Baba K; Harada T; Serikawa M; Ishii Y; Nakamura S; Arihiro K; Murakami Y; Takahashi S
    Langenbecks Arch Surg; 2023 Nov; 408(1):445. PubMed ID: 37999810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of initial recurrence site on the prognosis of different tissue types of non-small cell lung cancer: a retrospective cohort study.
    Li Y; Liu L; You R; Li Q; Jiang Z; Pu H; Li Z; Chen X
    World J Surg Oncol; 2023 Nov; 21(1):360. PubMed ID: 37986082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer.
    Chung MJ; Lee KJ; Bang S; Park SW; Kim KS; Lee WJ; Song SY; Chung JB; Park JY
    Ann Surg Oncol; 2011 Jun; 18(6):1651-6. PubMed ID: 21210227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.